Teva Pharmaceutical Industries Limited (TEVA) Provides Updated 2012 Non-GAAP Financial Outlook; Updated 2012 Non-GAAP Diluted EPS of $5.30 to $5.40
5/24/2012 10:39:16 AM
JERUSALEM--(BUSINESS WIRE)--On its conference call today, Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) provided its current outlook for non-GAAP financial performance for the full year ending December 31, 2012. This outlook is summarized below.
comments powered by